A2 Bio

WebsiteDirections Contact us

CouponFollow Extension

$80000000
OFF

Founder Lodge | A2 Biotherapeutics, Inc. Raises $80,000,000 At …

3 weeks from now

Jan 10, 2025 · A2 Biotherapeutics, Inc. raises $80,000,000 at Series C on 2025-01-10 in …

founderlodge.com

$80
OFF

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025 · AGOURA HILLS, Calif., January 09, 2025--A2 Biotherapeutics, Inc. (A2 Bio), a …

yahoo.com

$3
OFF

Founder Lodge | 225+ Founders $3.2B Raised On LinkedIn: A2 ...

3 weeks from now

A2 Biotherapeutics, Inc. raised $80,000,000 in Series C-Congrats Jim Robinson Full Round …

linkedin.com

$80
OFF

A2 Biotherapeutics Secures $80M Series C To Advance Logic …

3 weeks from now

Jan 17, 2025 · A2 Biotherapeutics, Inc., a clinical-stage company specialising in logic-gated …

pharmasource.global

$8800000
OFF

Founder Lodge | Biosphere Raises $8,800,000 At Seed On 2025-01-10

3 weeks from now

Jan 10, 2025 · Biosphere raises $8,800,000 at Seed on 2025-01-10 in Manufacturing, industry …

founderlodge.com

$80
OFF

A2 Bio Closes $80 Million Series C Financing Round

3 weeks from now

Jan 9, 2025 · Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on …

pacbiztimes.com

$8412690
OFF

Founder Lodge | Abselion Raises $8,412,690 At Series A On 2024-12 …

3 weeks from now

10/12/2024; Series A; $8,412,690 ; Our mission at Abselion is to simplify protein quantification …

founderlodge.com

$4000000
OFF

Founder Lodge | RyboDyn Inc. Raises $4,000,000 At Pre-Seed On …

3 weeks from now

10/01/2025; Pre-Seed; $4,000,000 ; RyboDyn, Inc. is targeting the dark proteome to make new …

founderlodge.com

FAQs about A2 Bio Coupon?

What is A2 Biotherapeutics?

A2 Biotherapeutics, established in 2018, is a fully integrated discovery, development and manufacturing organization. With over 40 staff located in Agoura Hills, California, the company has raised $136M since inception. A2 Biotherapeutics is a fully integrated discovery, development and manufacturing organization with more than 40 staff located in Agoura Hills, California. The company has raised $136M since inception. ...

What is a2b530 cell therapy?

A2B530 is the first autologous logic-gated cell therapy developed from A2 Bio’s proprietary Tmod TM platform. The Tmod platform utilizes a dual-receptor design consisting of an activator that targets tumor cells and a blocker that protects normal cells. ...

Is a2b530 a novel investigational cell therapy for colorectal cancer?

Novel investigational cell therapy A2B530 currently being evaluated in EVEREST-1 Phase 1 trial granted Orphan Drug Designation for the treatment of germline heterozygous HLA-A*02 (+) patients with colorectal cancer that expresses CEA and has lost HLA-A*02 expression ...

What is a2b530 and how does it work?

A2B530 consists of an activator that targets CEA and a blocker that targets HLA-A*02. Enrollment is ongoing in EVEREST-1 (NCT05736731 ), a seamless Phase 1/2 study to evaluate safety and efficacy of A2B530 in colorectal, pancreatic and non-small cell lung cancers. ...

Does orphan drug designation qualify for a2b530?

Orphan Drug Designation qualifies A2 Bio for certain development incentives related to the A2B530 clinical program, including tax credits for clinical trials, prescription drug user fee exemptions and potentially up to seven years of market exclusivity upon regulatory approval. ...